The direct medical costs of α1-antitrypsin deficiency

Chest

Volumn 119, Issue 3, 2001, Pages 745-752

  Mullins, C Daniel ^a   Huang, Xingyue ^a   Merchant, Sanjay ^a   Stoller, James K ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cost; Registry; 1 antitrypsin deficiency

Indexed keywords

ALPHA 1 ANTITRYPSIN;

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; COMORBIDITY; DISEASE ASSOCIATION; DRUG COST; FEMALE; HEALTH CARE COST; HUMAN; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; QUESTIONNAIRE; REGISTER;

EID: 0035096397     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.119.3.745     Document Type: Article

References (15)

1. 1-antitrypsin deficiency
2. 1-antitrypsin deficiency in Italy
3. 1-antitrypsin deficiency: Roger S. Mitchell lecture
4. 1-antitrypsin deficiency detected by screening of 200,000 infants
5. 1-antitrypsin deficiency
6. 1-antitrypsin deficiency: High prevalence in the St. Louis area determined by direct population screening
7. 1-antitrpsin deficiency
8. 1-antitrypsin deficiency
9. 1-antitrypsinreplacement therapy in treatment of congenital chronic obstructive pulmonary disease
10. 1-antitrypsin deficiency? A critical review and cost- effectiveness analysis
11. 1-antitrypsin deficiency
12. Cost and outcome of care for patients with chronic obstructive lung disease: Analysis by physician specialty
13. The cost and efficacy of home care for patients with chronic lung disease